Epigenetic silencing of tumor suppressor candidate 3 confers adverse prognosis in early colorectal cancer

Colorectal cancer (CRC) is a biologically and clinically heterogeneous disease. Even though many recurrent genomic alterations have been identified that may characterize distinct subgroups, their biological impact and clinical significance as prognostic indicators remain to be defined. The tumor sup...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Burgermeister, Elke, Höde, Patrick, Betge, Johannes, Gutting, Tobias, Merkel, Andreas, Wu, Wen, Tänzer, Marc, Mossner, Maximilian, Nowak, Daniel, Magdeburg, Julia, Rückert, Felix, Sticht, Carsten, Breitkopf-Heinlein, Katja, Schulte, Nadine, Härtel, Nicolai, Belle, Sebastian, Post, Stefan, Gaiser, Timo, Heppner, Barbara Ingold, Behrens, Hans-Michael, Röcken, Christoph, Ebert, Matthias P.A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2017
Soggetti:
Priority Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5689568/
https://ncbi.nlm.nih.gov/pubmed/29156678
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20950
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi